Fierce Pharma
DECEMBER 9, 2022
AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla. fkansteiner. Fri, 12/09/2022 - 09:22.
Medgadget
DECEMBER 7, 2022
At the University of South Australia, researchers designed a system that allows them to measure a patient’s blood pressure with a camera. The camera visualizes the patient’s forehead and focuses on two regions in particular to optically determine photoplethysmographic signals that AI algorithms then convert to blood pressure data. The researchers tested their system in 25 volunteers, and so far it has proven to be approximately 90% as accurate as traditional pressure cuff measurements.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 8, 2022
Kite Pharma and Daiichi Sankyo have updated a partnership agreement signed in 2017 for the former’s CAR T-cell therapy, Yescarta (axicabtagene ciloleucel). Under the prior deal, Daiichi Sankyo acquired exclusive rights for the development, manufacturing and commercialisation of Yescarta in Japan. Subsequently, in the same year, Gilead Sciences acquired Kite.
pharmaphorum
DECEMBER 7, 2022
Elon Musk’s brain computer interface (BCI) company Neuralink is being investigated by law enforcement authorities in the US amid allegations of animal welfare violations in its testing facilities. Neuralink’s BCI is intended to treat conditions like blindness and spinal cord injury, as well as provide a way to interact with digital devices using the brain and, according to Musk, is on the brink of moving into the human testing stage.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
DECEMBER 7, 2022
GSK, Sanofi, Pfizer and Boehringer Ingelheim free from federal Zantac litigation with new ruling. zbecker. Wed, 12/07/2022 - 10:05.
PharmExec
DECEMBER 8, 2022
Our annual report spotlighting notable investments in new drug development captures a mix of gradual gains and giant leaps—both equally as promising—in five expanding and diverse therapeutic areas: spinal muscular atrophy, hemophilia A, intranasal and inhaled vaccines, gene-targeted therapy, and RNA therapeutics.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
European Pharmaceutical Review
DECEMBER 8, 2022
Geron’s CEO Chip Scarlett spoke to EPR to explain the science behind Imetelstat, the company’s leading telomerase inhibitor candidate. If successful, imetelstat could become the first-ever cancer treatment based on the inhibition of telomerase, helping to treat lower-risk myelodysplastic syndromes (LR MDS) , which leaves many patients dependent on blood transfusions.
Fierce Pharma
DECEMBER 9, 2022
ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead. aliu. Fri, 12/09/2022 - 09:15.
Healthcare Success
DECEMBER 6, 2022
Healthcare consumers continue to move swiftly down the paths of least resistance toward quality care. This spells trouble for healthcare organizations that cannot change with the times. It’s time to pay attention to what competitors offer and find ways to remove unnecessary obstacles to care. In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. 9 Healthcare Marketing Trends 2023. 1.
MedCity News
DECEMBER 6, 2022
Taking the opposite approach of targeted protein degradation, biotech company Entact Bio is developing medicines that stabilize proteins and even enhances their function. This approach that could apply to cancer and certain rare diseases and Entact’s $81 million in Series A financing enables it to work on multiple programs in parallel.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
DECEMBER 5, 2022
A digital health assistant that can help people at risk of becoming dependent on alcohol has been launched in Belize, its first country, by the World Health Organisation (WHO) and Pan-American Health Organisation (PAHO). The artificial intelligence-powered assistant – called Pahola and available as a free online chat-based site – is designed to provide information and guidance to help people reduce their alcohol consumption, helping to prevent more than 200 health conditions linked to excessive
Fierce Pharma
DECEMBER 9, 2022
Combo of Roche's Tecentriq and Exelixis' Cabometyx fails another trial, this time in lung cancer. fkansteiner. Fri, 12/09/2022 - 11:22.
European Pharmaceutical Review
DECEMBER 8, 2022
Phase II trial results from the largest global head-to-head trial of programmed death receptor (PD-1) inhibitors in patients with metastatic non-squamous non-small cell lung cancer ( NSCLC ), showed a median progression-free survival (mPFS) of 8.8 months for patients treated with Jemperli (dostarlimab) plus chemotherapy versus 6.7 months for those given pembrolizumab and chemotherapy.
MedCity News
DECEMBER 9, 2022
Women’s health has been historically underfunded — in terms of both research dollars and venture capital investment. Lawmakers can’t craft effective policy nor can startups innovate in the women’s health space without good data and research, said panelists at a recent healthcare conference in Washington, D.C.
PharmExec
DECEMBER 8, 2022
Kimberly Moran, head of rare diseases in the US for UCB, started off working in medicine but quickly learned the importance of the business side of industry—and its role in helping improve the diagnosis and access paths for underserved patient segments.
Fierce Pharma
DECEMBER 5, 2022
AstraZeneca partner FibroGen slaps former employees with trade secret theft lawsuit. zbecker. Mon, 12/05/2022 - 10:31.
Pharmaceutical Technology
DECEMBER 7, 2022
Health Canada has granted approval for a supplement to a New Drug Submission (sNDS) of Novavax ’s Covid-19 vaccine (Recombinant protein, Adjuvanted), Nuvaxovid (NVX-CoV2373), for use in adolescents aged 12 to 17 years. The vaccine is indicated to be administered as a primary regimen comprising two doses for active immunisation to prevent Covid-19 in adolescents of this age group.
MedCity News
DECEMBER 7, 2022
Hospital and health system revenue cycles will face a labor shortage and external economic pressures for the indefinite future. Automation can help streamline and optimize healthcare revenue cycles, but organizations must use this enabling technology with strategic intent.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
European Pharmaceutical Review
DECEMBER 5, 2022
Novartis has announced its Phase III PSMAfore study with Pluvicto , lutetium (177Lu) vipivotide tetraxetan, demonstrated improved radiographic progression-free survival (rPFS) in patients with prostate-specific membrane antigen (PSMA)–positive metastatic castration-resistant prostate cancer (mCRPC) after androgen-receptor pathway inhibitor (ARPI) therapy, compared to a change in ARPI.
Fierce Pharma
DECEMBER 6, 2022
Emergent snags speedy FDA review, potentially teeing up over-the-counter Narcan by next spring. fkansteiner. Tue, 12/06/2022 - 10:58.
pharmaphorum
DECEMBER 4, 2022
Clinical trials of a wireless brain chip developed by Elon Muck’s Neuralink company will be tested in human volunteers within the next six months – and Musk himself says he intends to have one implanted for a future demo event. Neuralink has been promising that the technology will be ready for clinical trials soon for some time – first saying they were around the corner back in 2019 – so the latest announcement by Musk at an update last week may be met with some scepticism.
MedCity News
DECEMBER 7, 2022
Of these 18 million people, 3.8 million people will become completely uninsured, according to the Urban Institute’s report. The estimate is higher than HHS’ August prediction of 15 million people losing coverage after the public health emergency.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmaceutical Commerce
DECEMBER 8, 2022
Stakeholders are investing heavily in their ability to curate appropriate data sets and devise advanced data-analytics capabilities to harness real-world evidence (RWE) across the entire pharma lifecycle—from drug discovery and development through product launch and commercialization.
Fierce Pharma
DECEMBER 8, 2022
Merck escapes nearly 1,200 Zostavax shingles vaccine lawsuits as plaintiffs' testimony falls short. fkansteiner. Thu, 12/08/2022 - 09:22.
European Pharmaceutical Review
DECEMBER 9, 2022
According to a new market report by ResearchAndMarkets, the global oligonucleotide synthesis market is projected to reach $16.7 billion by 2027 during the forecast period, due to the rise in ongoing clinical trials for oligonucleotide-based therapies in key therapeutic sectors such as oncology. The research projected a compound annual growth rate (CAGR) of 16.8 percent from $7.7 billion in 2022.
MedCity News
DECEMBER 9, 2022
Enthea, a benefit plan administrator, works with self-insured employers to provide insurance coverage for psychedelic-assisted therapy. The company has gained $2 million in seed funding, led by Tabula Rasa Ventures. With the money, it is planning a nationwide rollout.
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
pharmaphorum
DECEMBER 6, 2022
Clinical trials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck in the past. Recognising an opportunity to develop better tools for clinical trial leaders to share and stream data, YonaLink’s co-founders built a software solution that addresses the interoperability gap in clinical trial operations.
Fierce Pharma
DECEMBER 7, 2022
Troubled Endo shelves cellulite treatment Qwo, lays off 90 employees. kdunleavy. Wed, 12/07/2022 - 09:47.
European Pharmaceutical Review
DECEMBER 9, 2022
The Global Antimicrobial Resistance and Use Surveillance System (GLASS) report 2022 by the World Health Organization (WHO), which contains AMR trends for the first time since 2017, showed that common bacterial infections are becoming increasingly resistant to treatments. Data from the 2022 GLASS report. The document includes data on antimicrobial consumption (AMC) in humans in 27 countries and analyses for antimicrobial resistance (AMR) rates in relation to national testing coverage.
MedCity News
DECEMBER 9, 2022
Instead of trying to fix access issues by adding more office-based doctors, health systems should consider how to best implement a program that utilizes Virtualists for workforce expansion.
Expert insights. Personalized for you.
284 
Let's personalize your content